Digital health technologies can fill the current gaps in oncology care while rebalancing the existing oncology value framework. Digital technology is transforming every stage of cancer, allowing for substantially improved care and the removal of existing hurdles. It also helps in self-managing treatments, and providing useful Real World Evidence, this platform also assists patients in self-managing their conditions.Through this whitepaper, DelveInsight is presenting advancements that allow individualized care, with each cancer patient's demographic, clinical, and genetic profile, as well as their specific demands, being taken into account. Digital health solutions like ASyMS, AWARE, Bioconnect, Cankado, CHOICE, eDiary meet various needs of cancer patients and their caregivers. Technologies such as at-home diagnosis, in silico trials, implanted sensors, precision surgery, artificial intelligence, and others enable oncologists to help them in their tasks. These new tools will continue to change the way cancer patients are treated, and they are most effective when care professionals use them in tandem, improving industry data access and making it available to doctors all around the world.Also, give it a good read to <a href="https://www.delveinsight.com/blog/delveinsights-oncology-based-reports" rel="noopener noreferrer" target="_blank">Assessing the Opportunities and Challenges in the Oncology Segment</a>.

Digital health technologies can fill the current gaps in oncology care while rebalancing the existing oncology value framework. Digital technology is transforming every stage of cancer, allowing for substantially improved care and the removal of existing hurdles. It also helps in self-managing treatments, and providing useful Real World Evidence, this platform also assists patients in self-managing their conditions.

A Growing World of Digital Health in the Field of Oncology

Through A Growing World of Digital Health in the Field of Oncology whitepaper, DelveInsight is presenting advancements that allow individualized care, with each cancer patient's demographic, clinical, and genetic profile, as well as their specific demands,